204 related articles for article (PubMed ID: 15294457)
21. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam.
Lu XL; Yang SK
Mol Pharmacol; 1989 Dec; 36(6):932-8. PubMed ID: 2601688
[TBL] [Abstract][Full Text] [Related]
24. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
Meyer MR; Peters FT; Maurer HH
Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971
[TBL] [Abstract][Full Text] [Related]
25. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
26. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
Lin LY; Kumagai Y; Hiratsuka A; Narimatsu S; Suzuki T; Funae Y; Distefano EW; Cho AK
Drug Metab Dispos; 1995 Jun; 23(6):610-4. PubMed ID: 7587941
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
[TBL] [Abstract][Full Text] [Related]
29. Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine.
Lin LY; Fujimoto M; Distefano EW; Schmitz DA; Jayasinghe A; Cho AK
J Pharmacol Exp Ther; 1996 May; 277(2):595-603. PubMed ID: 8627536
[TBL] [Abstract][Full Text] [Related]
30. Oxidative metabolism of flunarizine in rat liver microsomes.
Kariya S; Isozaki S; Narimatsu S; Suzuki T
Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):85-95. PubMed ID: 1462051
[TBL] [Abstract][Full Text] [Related]
31. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
32. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes.
Itoh K; Nishiya Y; Takasaki W; Adachi M; Tanaka Y
Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492
[TBL] [Abstract][Full Text] [Related]
33. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
Fontaine SM; Mash EA; Hoyer PB; Sipes IG
Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
[TBL] [Abstract][Full Text] [Related]
34. Identification of cytochrome P450 enzymes involved in the metabolism of the designer drugs N-(1-phenylcyclohexyl)-3-ethoxypropanamine and N-(1-phenylcyclohexyl)-3-methoxypropanamine.
Sauer C; Peters FT; Schwaninger AE; Meyer MR; Maurer HH
Chem Res Toxicol; 2008 Oct; 21(10):1949-55. PubMed ID: 18778087
[TBL] [Abstract][Full Text] [Related]
35. Capillary electrophoretic investigation of the enantioselective metabolism of propafenone by human cytochrome P-450 SUPERSOMES: Evidence for atypical kinetics by CYP2D6 and CYP3A4.
Afshar M; Thormann W
Electrophoresis; 2006 Apr; 27(8):1526-36. PubMed ID: 16609933
[TBL] [Abstract][Full Text] [Related]
36. Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone.
Peters FT; Meyer MR; Theobald DS; Maurer HH
Drug Metab Dispos; 2008 Jan; 36(1):163-8. PubMed ID: 17962373
[TBL] [Abstract][Full Text] [Related]
37. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
Echizen H; Mochizuki K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963
[TBL] [Abstract][Full Text] [Related]
38. Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine.
Sauer C; Peters FT; Schwaninger AE; Meyer MR; Maurer HH
Biochem Pharmacol; 2009 Feb; 77(3):444-50. PubMed ID: 19022226
[TBL] [Abstract][Full Text] [Related]
39. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
Kraemer T; Bickeboeller-Friedrich J; Maurer HH
Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
[TBL] [Abstract][Full Text] [Related]
40. The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
Chauret N; Dobbs B; Lackman RL; Bateman K; Nicoll-Griffith DA; Stresser DM; Ackermann JM; Turner SD; Miller VP; Crespi CL
Drug Metab Dispos; 2001 Sep; 29(9):1196-200. PubMed ID: 11502727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
